Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to advance cancer therapy ...

Cancer treatment is becoming more personalised. By considering a patient’s unique genetic and molecular profile, along with their lifestyle and environmental factors, doctors can make more accurate ...

Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations, but it has been difficult to discern whether they play an active role in ...

Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next ...

Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PharosAI brings together King's College London, ...

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

A team of cancer genomics scientists from The University of Manchester and The Institute of Cancer Research, London, forensically examined the genetic make-up of tumors in 16 different cancers. Their ...

The Milner Therapeutics Institute launched a new functional genomics screening laboratory (FGSL) in Cambridge, U.K. The lab will support research and innovation in functional genomics, which explores ...